ArticleCell death & disease2026
RET receptor tyrosine kinase promotes breast cancer metastasis to the brain and RET inhibitors pralsetinib and selpercatinib suppress breast cancer brain metastases.
Angelina T Regua et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.